The More You Know About Cancer Prevention
Recent studies found awareness gaps about cancer prevention strategies such as screening and vaccination may reduce who benefits from...
Recent studies found awareness gaps about cancer prevention strategies such as screening and vaccination may reduce who benefits from...
A string of innovative clinical trials designed to accelerate the pace at which personalized cancer medicines are developed have...
Compared to treatment advances for other types of cancer, progress in treating brain cancer has been frustratingly slow. Still,...
“The field of cell therapy is one of the most exciting fields in translational medicine,” began Katayoun Rezvani, MD, PhD,...
This past week has included good news for some patients with lung cancer and bad news for those with...
Breast cancer is the most commonly diagnosed cancer in the United States. In 2018, 266,120 women and 2,550 men...
It is an exciting era for drug development in oncology. The many discoveries of new molecular targets, coupled with...
The second day of the AACR Virtual Annual Meeting II began with a clinical trials plenary session. Two of the session’s presentations, which focused on immunotherapy clinical...
This year, the American Association for Cancer Research (AACR) launched a series of Patient Advocate Forums, virtual conversations featuring...
Guest Post by Robert L. Strausberg, PhD Ludwig Institute for Cancer Research
The latest installment of this quarterly series highlights innovative research approaches reported at the AACR Annual Meeting 2024.
Breast cancer researchers are packed up in San Antonio, eager to build on the latest information they gathered at...
Monday ushered in a ray of hope and promise for the lung cancer community at the AACR Annual Meeting...
NCI Director Kimryn Rathmell evoked Taylor Swift to present her vision of the 360 era for cancer research.
While there have been great strides in lowering the incidence and mortality rates of cervical cancer in the United...
Hot on the heels of the FDA’s landmark approval of an anticancer therapeutic for use based on whether a...
In part 4 of our 2024 Experts Forecast, Paul Workman, PhD, shares thoughts on cutting-edge advances in oncology drug...
Cancer cells ingest copious amounts of the simple sugar glucose. This addiction may hold the key to how cancer...
As we keep an eye out for those promised May flowers, we bring you the latest round of Editors’...
Editor’s Note: Raquel Castellanos is assistant director of Scientific Programs at the American Association for Cancer Research. She and...
Guest Post by Wafik S. El-Deiry, MD, PhD, FACP Fox Chase Cancer Center
Our immune systems are equipped to recognize and destroy cancer cells—if they can find them, that is. And with...
In a study published in the AACR’s journal Clinical Cancer Research, a team of scientists from the University of...
Lobular breast cancer accounts for 15% of all breast cancer cases, but it is understudied.
The milieu of cells, proteins, and vasculature that comprise the tumor microenvironment can hinder efforts to treat cancer. This...
In 2017, electronic cigarettes (e-cigarettes) were the most commonly used tobacco product among high and middle school students. Many...
This month, the Early Detection Research Network (EDRN) marks its 20th anniversary. The National Cancer Institute (NCI) launched the...
“What will you do Monday morning?” was the question posed by the final session on the final full day...
The AACR Annual Meeting 2023 kicks off Friday, April 14, with thousands of cancer researchers from around the world...
Pancreatic cancer is projected to become the second leading cause of cancer mortality in the United States by 2030....